Ruconest 2100 U lyophilized powder for injection Images
Generic Name: conestat alfa
This medication has been identified as Ruconest 2100 U lyophilized powder for injection. It is supplied by Pharming Healthcare Inc.
Ruconest is used in the treatment of Hereditary Angioedema and belongs to the drug class hereditary angioedema agents. There is no proven risk in humans during pregnancy. Ruconest 2100 U lyophilized powder for injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Ruconest
- Generic Name
- conestat alfa
- Strength
- 2100 U lyophilized powder for injection
- Availability
- Prescription only
- Drug Class
- Hereditary angioedema agents
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Pharming Healthcare Inc.
- National Drug Code (NDC)
- 71274-0350
See also:
Firazyr
Firazyr is used to treat acute attacks of hereditary angioedema (HAE) in adults. It can be ...
Cinryze
Cinryze (complement C1 esterase inhibitor) is used to prevent attacks of angioedema in people with ...
Orladeyo
Orladeyo (berotralstat) is used to prevent attacks of hereditary angioedema (HAE). Includes ...
Haegarda
Haegarda is an injectable protein replacement therapy that prevents swelling and attacks in ...
Takhzyro
Takhzyro (lanadelumab-flyo) is used to prevent hereditary angioedema (HAE) and reduce symptoms ...
More about Ruconest (conestat alfa)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (3)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- FDA approval history
- Drug class: hereditary angioedema agents
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.